← Leaderboards
David H Abbott
University Of Wisconsin Madison
$5,539,798
Attributed
$5,806,738
Total exposure
37
Grants
18
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–21$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$5,806,738 · 37
By mechanism
P51$4,437,940 · 34
R01$968,388 · 1
R21$400,410 · 1
P50$0 · 1
Top collaborators
- Jon E Levine2 shared
- Jeffrey A Rogers2 shared
Most similar at University Of Wisconsin Madison
Same institution · by research overlap
- Richard E Peterson$8,678,169
- Chad M Vezina$11,718,158
- Daniel G Petereit$11,644,574
- George Wilding$32,976,854
- Ei None Terasawagrilley$11,660,800
Others in their field
Top investigators on “Female”
- Philip J Disaia · University Of California Irvine$140,003,514
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$103,542,269
- Wafaa M. El-Sadr · Columbia University Health Sciences$102,372,214
- Myron S Cohen · Family Health International$101,800,876
- Walter John Curran · Thomas Jefferson University$57,608,324
- Gregory S Boebinger · Florida State University$55,673,680
Research focus
FemalePrimatesNonhuman PrimateSourceGrantFundingPolycystic Ovary SyndromeUnited States National Institutes Of HealthResourcesServicesAndrogensMacaca MulattaAnimalsResearch PersonnelComputer Retrieval Of Information On Scientific Projects DatabaseInstitutionAnimal ColonyWisconsinWomanAffectInsulinAdultFetusPregnancy
Grant awards (49)
Whole exome analyses in naturally occurring hyperandrogenic female monkeys$174,051
R21 · FY2021 · HD
Whole exome analyses in naturally occurring hyperandrogenic female monkeys$226,359
R21 · FY2020 · HD
NATURALLY-OCCURRING POLYCYSTIC OVARY SYNDROME (PCOS) IN NONHUMAN PRIMATES$148,531
P51 · FY2011 · RR · contact PI
RESTORING NORMAL FREQUENCY AND DURATION OF FEMALE SEXUAL BEHAVIOR$46,099
P51 · FY2011 · RR · contact PI
MECHANISM OF ACTION OF NOVEL HORMONE THERAPIES IN ADULT MALE RHESUS MONKEYS$34,390
P51 · FY2011 · RR · contact PI
POLYCYSTIC OVARY SYNDROME (PCOS) AND FETAL, NEONATAL AND ADULT BIOMARKERS$2,489
P51 · FY2011 · RR · contact PI
RESTORING NORMAL FREQUENCY AND DURATION OF FEMALE SEXUAL BEHAVIOR$30,981
P51 · FY2010 · RR · contact PI
NATURALLY-OCCURRING POLYCYSTIC OVARY SYNDROME (PCOS) IN NONHUMAN PRIMATES$30,981
P51 · FY2010 · RR · contact PI
POLYCYSTIC OVARY SYNDROME (PCOS) AND FETAL, NEONATAL AND ADULT BIOMARKERS$30,981
P51 · FY2010 · RR · contact PI
EFFECTIVE DETECTION OF PCOS IN OLD WORLD MONKEYS$21,939
P51 · FY2010 · RR · contact PI
POLYCYSTIC OVARY SYNDROME AND FETAL AND NEONATAL BIOMARKERS$46,835
P51 · FY2009 · RR · contact PI
RESTORING NORMAL FREQUENCY AND DURATION OF FEMALE SEXUAL BEHAVIOR$46,835
P51 · FY2009 · RR · contact PI
POLYCYSTIC OVARY SYNDROME AND FETAL AND NEONATAL BIOMARKERS$81,915
P51 · FY2008 · RR · contact PI
RESTORING NORMAL FREQUENCY AND DURATION OF FEMALE SEXUAL BEHAVIOR$81,915
P51 · FY2008 · RR · contact PI
OAR FUNDING FOR ENHANCEMENT OF FACILITIES FOR AIDS RELATED RESEARCH$196,043
P51 · FY2007 · RR · contact PI
POLYCYSTIC OVARY SYNDROME AND FETAL AND NEONATAL BIOMARKERS$62,967
P51 · FY2007 · RR · contact PI
RESTORING NORMAL FREQUENCY AND DURATION OF FEMALE SEXUAL BEHAVIOR$62,967
P51 · FY2007 · RR · contact PI
PRIMATE RESOURCE AND FACILITIES OPERATIONS: AIDS$529,420
P51 · FY2006 · RR · contact PI
GNRH II STIMULATION AND SEXUAL DYSFUNCTION$27,215
P51 · FY2006 · RR · contact PI
POLYCYSTIC OVARY SYNDROME AND FETAL AND NEONATAL BIOMARKERS$27,215
P51 · FY2006 · RR · contact PI
NEW SECURITY SYSTEM$692,841
P51 · FY2005 · RR
SUPPLIES, EQUIPMENT AND OTHER EXPENSES$531,757
P51 · FY2005 · RR
TRAINING OF PERSONNEL FROM INDIA OR CHINA IN PRIMATOLOGY$160,000
P51 · FY2005 · RR
EFFICACY OF AF2364 AS A NEW ORAL CONTRACEPTIVE FOR MALES$34,795
P51 · FY2005 · RR
FETAL AND NEONATAL BIOMARKERS OF PCOS$34,795
P51 · FY2005 · RR
MARMOSET AND TAMARIN MODELS FOR BIOMEDICAL RESEARCH$34,795
P51 · FY2005 · RR
NEUROENDOCRINE REGULATION OF SOCIALLY-INDUCED ANOVULATION$34,795
P51 · FY2005 · RR
IMPAIRED OOCYTE DEVELOPMENTAL COMPETENCE IN A NONHUMAN PRIMATE MODEL FOR PCOS$34,795
P51 · FY2005 · RR
PRENATAL ANDROGEN EXCESS IN FEMALES PROGRAMS FOR PCOS$34,795
P51 · FY2005 · RR
OVARIAN AND ADRENAL HYPERANDROGENISM IN A NONHUMAN PRIMATE MODEL FOR PCOS$34,795
P51 · FY2005 · RR
ADRENOCORTICAL FUNCTION IN FEMALE MARMOSET MONKEYS$34,795
P51 · FY2005 · RR
PHYSIOLOGICAL MECHANISMS UNDERLYING DIABETES AND OBESITY$34,795
P51 · FY2005 · RR
GNRH II STIMULATION OF FEMALE MARMOSET SEXUAL BEHAVIOR$34,795
P51 · FY2005 · RR
MARMOSET AND TAMARIN MODELS FOR BIOMEDICAL RESEARCH$280,464
P51 · FY2004 · RR
OVARIAN AND ADRENAL HYPERANDROGENISM IN A PRIMATE MODEL$112,153
P51 · FY2004 · RR
PHYSIOLOGICAL MECHANISMS UNDERLYING DIABETES AND OBESITY$112,153
P51 · FY2004 · RR
EFFICACY OF AF2364 AS A NEW ORAL CONTRACEPTIVE FOR MALES$112,153
P51 · FY2004 · RR
GNRH II STIMULATION OF FEMALE MARMOSET SEXUAL BEHAVIOR$112,153
P51 · FY2004 · RR
FETAL AND NEONATAL BIOMARKERS OF PCOS$112,153
P51 · FY2004 · RR
PRENATAL ANDROGEN EXCESS IN FEMALES PROGRAMS FOR PCOS$112,153
P51 · FY2004 · RR
NEUROENDOCRINE REGULATION OF SOCIALLYINDUCED ANOVULATION$112,153
P51 · FY2004 · RR
WNPRC ASSAY SERVICES UNIT$84,115
P51 · FY2004 · RR
ANDROGENIZED FEMALE AS A MODEL FOR P0LYCYSTIC OVARIAN SY$324,419
R01 · FY2002 · RR
Fetal Androgen Induces Ovarian, LH and B-Cell Defects$0
P50 · FY2002 · HD
ANDROGENIZED FEMALE AS A MODEL FOR P0LYCYSTIC OVARIAN SY$326,977
R01 · FY2001 · RR
OVARIAN HYPERANDROGENISM IN RHESUS EXPOSED TO PRENATAL ANDROGEN: PCOS MODEL$0
P51 · FY2001 · RR
HYPERLIPIDEMIA IN PRENATALLY ANDROGENIZED FEMALE RHESUS MONKEYS$0
P51 · FY2001 · RR
ANDROGENIZED FEMALE AS A MODEL FOR P0LYCYSTIC OVARIAN SY$316,992
R01 · FY2000 · RR
OVARIAN HYPERANDROGENISM IN RHESUS EXPOSED TO PRENATAL ANDROGEN: PCOS MODEL$46,024
P51 · FY2000 · RR